Physician profile
Amy E Bailey
NPI 1275731580
$969.90
in general payments reported to CMS, 2019-2025
18 companies · $32.62 in 2025
The $32.62 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $70.11 · 2022: $208 · 2023: $71.32 · 2024: $73.54 · 2025: $32.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $191.60 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $121.89 | 2022-2024 | Qulipta |
| Sanofi-Aventis U.S. LLC | $84.98 | 2019-2020 | |
| Abbott Laboratories | $66.65 | 2022 | |
| Glaxosmithkline, LLC. | $65.89 | 2019-2025 | Shingrix, Bexsero, Arexvy |
| Astellas Pharma US INC | $51.57 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $48.99 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $47.54 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.20 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $40.17 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.60 | 2019 | |
| Dexcom, INC. | $38.49 | 2022-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $37.95 | 2019-2022 | |
| Amgen INC. | $35.52 | 2019 | |
| Sanofi Pasteur INC. | $15.76 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.00 | 2022 | |
| Medtronic USA, INC. | $12.26 | 2019 | |
| Echosens North America, INC. | $11.84 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.